Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
75 /100
HIGH RISK
Score updated Oct 13, 2026

OVID — Ovid Therapeutics Inc. Dilution Risk Tracker

Track OVID dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OVID — Get alerts when the score changes →

As of October 13, 2026, Ovid Therapeutics Inc. (OVID) has a DilutionWatch DilutionScore of 75/100, rated HIGH dilution risk. Ovid Therapeutics Inc. has a market capitalization of $470.67M, 195.30M shares outstanding, 104 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $60.00M, ATM program capacity of $60.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
95
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
model est. 57%
💰 Capital Raise model 93%
• Critical: only 2.6 months cash remaining
• Active shelf registration ($60M, 13% of market cap)
🔄 Reverse Split model est. 30%
• 52-week low $0.27 has breached $1
• Only 3 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (75/100)
🔔 Track OVID — Get forecast alerts →

Market Data

Market Cap$470.67M
Shares Outstanding195.30M
Float161.29M
Cash$11.33M
Debt$13.07M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore75/100DilutionWatch score record
Shares Outstanding195.30MVerified float table or market cache
Public Float161.29MVerified float table or market cache
Market Cap$470.67MMarket data cache
Cash Runway2.6 monthsDilutionWatch score inputs
Shelf Capacity$60.00MSEC-derived dilution fields
ATM Capacity$60.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, 424B3 1, 8-K 1, EFFECT 1, S-3 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 83.6% shares (2026Q1 vs prior)
104 institutional holders · 122.49M shares
#1 JANUS HENDERSON GROUP PLC 21.43M shares
#2 RA CAPITAL MANAGEMENT, L.P. 10.71M shares
#3 Affinity Asset Advisors, LLC 10.64M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.95M
Days to Cover8.9
% of Float11.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2023-03-13
424B3 ATM 2026-04-27
EFFECT EFFECT 2026-04-24
S-3 SHELF 2026-04-21
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual OVID Dilution Snapshot

Ovid Therapeutics Inc. (OVID) has a DilutionScore of 75/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

OVID's DilutionScore is currently 75/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 54/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202675/100HIGH53 days
Jul 17 – Aug 21, 202654/100HIGH35 days
Jul 16, 202653/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

OVID shares outstanding have increased 162.1% from 71.21M (Mar 2026) to 186.64M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 2026186.64M161.29M▲ 41.53%
May 01, 2026173.04M113.96M▲ 12.59%
Mar 27, 2026151.03M101.22M▲ 0.40%
Mar 26, 2026151.03M100.82M▲ 85.19%
Mar 13, 202671.21M54.44M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track OVID Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment OVID files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking OVID — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OVID
OVID FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.